Selective G2/M arrest in a p53Val135-transformed cell line induced by lithium is mediated through an intricate network of MAPK and β-catenin signaling pathways

Life Sciences

Volumn 91, Issue 9-10, 2012, Pages 312-321

  Tsui, Marco Man Kin ^a,b   Tai, William Chi Shing ^a   Wong, Wing Yan ^a   Hsiao, Wen Luan Wendy ^a  

^a HONG KONG BAPTIST UNIVERSITY   (Hong Kong)

^b OKINAWA INSTITUTE OF SCIENCE AND TECHNOLOGY GRADUATE UNIVERSITY   (Japan)

Author keywords

catenin; G2 M arrest; Lithium; MAPK; p53

Indexed keywords

BETA CATENIN; LITHIUM; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN P53;

ANIMAL CELL; ARTICLE; CELL TRANSFORMATION; CELLULAR STRESS SIGNAL; CONTROLLED STUDY; DOWN REGULATION; EMBRYO; ENZYME PHOSPHORYLATION; FLUORESCENCE ACTIVATED CELL SORTING; G2 PHASE CELL CYCLE CHECKPOINT; M PHASE CELL CYCLE CHECKPOINT; NONHUMAN; NUCLEOTIDE SEQUENCE; RAT; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING;

ADENOCARCINOMA; ANIMALS; ANTIMANIC AGENTS; BETA CATENIN; BLOTTING, WESTERN; CELL LINE; CELL LINE, TUMOR; COLONIC NEOPLASMS; FIBROBLASTS; FLOW CYTOMETRY; G2 PHASE CELL CYCLE CHECKPOINTS; HUMANS; LITHIUM CHLORIDE; MAP KINASE SIGNALING SYSTEM; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; RATS; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53;

RATTUS;

EID: 84866113546     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2012.07.027     Document Type: Article

References (25)

1. A. Becchetti, and M. Whitaker Lithium blocks cell cycle transitions in the first cell cycles of sea urchin embryos, an effect rescued by myo-inositol Development 124 1997 1099 1107
2. A. Damalas, S. Kahan, M. Shtutman, A. Ben-Ze'ev, and Oren M Deregulated beta-catenin induces a p53- and ARF-dependent growth arrest and cooperates with Ras in transformation EMBO J 20 2001 4912 4922
3. A.S. Dhillon, S. Hagan, O. Rath, and W. Kolch MAP kinase signalling pathways in cancer Oncogene 26 2007 3279 3290
4. P. Dong, M. Tada, J. Hamada, A. Nakamura, T. Moriuchi, and N. Sakuragi p53 dominant-negative mutant R273H promotes invasion and migration of human endometrial cancer HHUA cells Clin Exp Metastasis 24 2007 471 483
5. S. Frame, and P. Cohen GSK3 takes centre stage more than 20 years after its discovery Biochem J 359 2001 1 16
6. J.C. Ghosh, and D.C. Altieri Activation of p53-dependent apoptosis by acute ablation of glycogen synthase kinase-3beta in colorectal cancer cells Clin Cancer Res 11 2005 4580 4588
7. F.K. Goodwin, and M.A. Goldstein Optimizing lithium treatment in bipolar disorder: a review of the literature and clinical recommendations J Psychiatr Pract 9 2003 333 343
8. Y. Hao, T. Creson, L. Zhang, P. Li, F. Du, and P. Yuan Mood stabilizer valproate promotes ERK pathway-dependent cortical neuronal growth and neurogenesis J Neurosci 24 2004 6590 6599
9. E. Levina, M. Oren, and A. Ben-Ze'ev Downregulation of beta-catenin by p53 involves changes in the rate of beta-catenin phosphorylation and Axin dynamics Oncogene 23 2004 4444 4453
10. C.D. Mao, P. Hoang, and P.E. DiCorleto Lithium inhibits cell cycle progression and induces stabilization of p53 in bovine aortic endothelial cells J Biol Chem 276 2001 26180 26188
11. D. Olmeda, S. Castel, S. Vilaro, and A. Cano Beta-catenin regulation during the cell cycle: implications in G2/M and apoptosis Mol Biol Cell 14 2003 2844 2860
12. M.L. Rodriguez de la Concepcion, P. Yubero, R. Iglesias, M. Giralt, and F. Villarroya Lithium inhibits brown adipocyte differentiation FEBS Lett 579 2005 1670 1674
13. N.R. Rodrigues, A. Rowan, M.E. Smith, I.B. Kerr, W.F. Bodmer, and J.V. Gannon p53 mutations in colorectal cancer Proc Natl Acad Sci U S A 87 1990 7555 7559
14. M.K. Rowe, and D.M. Chuang Lithium neuroprotection: molecular mechanisms and clinical implications Expert Rev Mol Med 6 2004 1 18
15. E. Sadot, B. Geiger, M. Oren, and A. Ben-Ze'ev Down-regulation of beta-catenin by activated p53 Mol Cell Biol 21 2001 6768 6781
16. C.J. Sherr Tumor surveillance via the ARF-p53 pathway Genes Dev 12 1998 2984 2991
17. A. Sigal, and V. Rotter Oncogenic mutations of the p53 tumor suppressor: the demons of the guardian of the genome Cancer Res 60 2000 6788 6793
18. F. Takahashi-Yanaga, Y. Taba, Y. Miwa, Y. Kubohara, Y. Watanabe, and M. Hirata Dictyostelium differentiation-inducing factor-3 activates glycogen synthase kinase-3beta and degrades cyclin D1 in mammalian cells J Biol Chem 278 2003 9663 9670
19. J. Tan, L. Zhuang, H.S. Leong, N.G. Iyer, E.T. Liu, and Q. Yu Pharmacologic modulation of glycogen synthase kinase-3beta promotes p53-dependent apoptosis through a direct Bax-mediated mitochondrial pathway in colorectal cancer cells Cancer Res 65 2005 9012 9020
20. J.A. Umbach, Y. Zhao, and C.B. Gundersen Lithium enhances secretion from large dense-core vesicles in nerve growth factor-differentiated PC12 cells J Neurochem 94 2005 1306 1314
21. J.M. Vargason, G. Szittya, J. Burgyan, and T.M. Hall Size selective recognition of siRNA by an RNA silencing suppressor Cell 115 2003 799 811
22. W. Wang, J.X. Chen, R. Liao, Q. Deng, J.J. Zhou, and S. Huang Sequential activation of the MEK-extracellular signal-regulated kinase and MKK3/6-p38 mitogen-activated protein kinase pathways mediates oncogenic ras-induced premature senescence Mol Cell Biol 22 2002 3389 3403
23. Q. Wang, Y. Zhou, X. Wang, and B.M. Evers Glycogen synthase kinase-3 is a negative regulator of extracellular signal-regulated kinase Oncogene 25 2006 43 50
24. J.W. Yam, J.Y. Zheng, and W.L. Hsiao Identification and characterization of genes whose expressions are altered in rat 6 fibroblasts transformed by mutant p53(val135) Biochem Biophys Res Commun 266 1999 472 480
25. K. Ye, L. Malinina, and D.J. Patel Recognition of small interfering RNA by a viral suppressor of RNA silencing Nature 426 2003 874 878